Amryt Pharma PLC (LSE:AMYT) - Share price - Overview

Stock Report

Amryt Pharma PLC AMYT

Last Price
GBX17.85

Day Change
0.33|1.85%

As of 19/07/2018
16:34:39 BST | GBX
Minimum 15 Minutes Delay.

Last Close17.53p
Day Range17.50 - 18.25
Mkt Cap48.16Mil
52-Wk Range15.60 - 26.30
Yield %-
ISINGB00BDD1LS57
Volume1,414,810
P/E-266.42
P/S3.13
P/CF-3.37

Share Price

Total Returns 18/07/2018

 Chg (%)  
More ...
Amryt Pharma PLC7.02 
FTSE 100 TR GBP1.18
 
Financials
201520162017
More ...
Income Statement
Turnover0.001.3512.78
Operating Profit-2.04-5.85-14.21
Net Profit-1.87-7.80-26.14
Reported EPS-0.04-0.05-0.12
Balance Sheet
Current Assets15.3511.5826.32
Non Current Assets0.0153.7053.77
Total Assets15.3665.2980.09
Current Liabilities0.463.559.80
Total Liabilities0.4632.2558.20
Total Equity14.9033.0421.89
Cash Flow
Operating Cash Flow-3.43-6.11-11.86
Net Change in Cash-0.588.1012.17
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/10/2017PurchaseRory Peter Nealon0.00221,5920.00
11/10/2017PurchaseHarry Thomas Stratford OBE0.00150,0000.00
11/10/2017PurchaseAnthony James Culverwell0.00221,5920.00
11/10/2017PurchaseDr. Joseph Amrit Wiley0.00221,5920.00

Company Profile

Amryt Pharma PLC is a specialty pharmaceutical company. The company is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 04/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-35.98
Op Mrgn-1.11
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorRaymond Thomas Stafford
Executive Director, Chief Financial Officer, COO and CSRory Peter Nealon
Non-Executive Director, ChairmanHarry Thomas Stratford OBE
Non-Executive DirectorAnthony James Culverwell
Executive Director, Chief Executive OfficerDr. Joseph Amrit Wiley
Non-Executive DirectorMr. Markus Ziener
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.